Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 528 | 598 | 659 | 0 | 0 |
| Marketable Securities | 612 | 616 | 601 | 0 | 0 |
| Receivables | 25 | 27 | 23 | 0 | 0 |
| Inventories | 6 | 10 | 15 | 0 | 0 |
| TOTAL | $1,171 | $1,250 | $1,298 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 330 | 345 | 342 | N/A | N/A |
| Investments And Advances | 12 | 12 | 12 | 0 | 0 |
| TOTAL | $342 | $357 | $354 | $N/A | $N/A |
| Total Assets | $1,513 | $1,607 | $1,652 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45 | 47 | 11 | 0 | 0 |
| TOTAL | $64 | $66 | $63 | $0 | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $59 | $63 | $67 | $N/A | $N/A |
| Total Liabilities | $123 | $130 | $130 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 622 | 622 | N/A | N/A | N/A |
| Common Shares | 6,648 | 6,648 | 6,648 | 0 | 0 |
| Retained earnings | -219 | -148 | -87 | 0 | 0 |
| Other shareholders' equity | -27 | -10 | -27 | 0 | 0 |
| TOTAL | $1,390 | $1,478 | $1,522 | $0 | $0 |
| Total Liabilities And Equity | $1,513 | $1,607 | $1,652 | $0 | $0 |